Perampanel-induced, new-onset food aversion in a 29-year-old female with medically refractory frontal lobe epilepsy
{{output}}
Background: Perampanel is a selective, noncompetitive amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor antagonist indicated for management of partial-onset and primary generalized seizures in epilepsy patient... ...
